411 related articles for article (PubMed ID: 28606917)
1. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpr redirects host ubiquitination pathway.
Arora S; Verma S; Banerjea AC
J Virol; 2014 Aug; 88(16):9141-52. PubMed ID: 24899191
[TBL] [Abstract][Full Text] [Related]
3. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
[TBL] [Abstract][Full Text] [Related]
4. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.
Yan J; Shun MC; Zhang Y; Hao C; Skowronski J
Proc Natl Acad Sci U S A; 2019 May; 116(19):9568-9577. PubMed ID: 31019079
[TBL] [Abstract][Full Text] [Related]
6. The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr.
Dupont L; Bloor S; Williamson JC; Cuesta SM; Shah R; Teixeira-Silva A; Naamati A; Greenwood EJD; Sarafianos SG; Matheson NJ; Lehner PJ
Cell Host Microbe; 2021 May; 29(5):792-805.e6. PubMed ID: 33811831
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Vpr Reprograms CLR4
Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
[TBL] [Abstract][Full Text] [Related]
8. Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.
Zhao L; Wang S; Xu M; He Y; Zhang X; Xiong Y; Sun H; Ding H; Geng W; Shang H; Liang G
Nat Commun; 2021 Jun; 12(1):3691. PubMed ID: 34140527
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.
Kogan M; Deshmane S; Sawaya BE; Gracely EJ; Khalili K; Rappaport J
J Cell Physiol; 2013 Apr; 228(4):781-90. PubMed ID: 23001849
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
[TBL] [Abstract][Full Text] [Related]
12. Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection.
Wang P; Meng Z; Deng K; Gao Z; Cai J
Virol J; 2024 Apr; 21(1):97. PubMed ID: 38671522
[TBL] [Abstract][Full Text] [Related]
13. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4
Bauby H; Ward CC; Hugh-White R; Swanson CM; Schulz R; Goujon C; Malim MH
mBio; 2021 Jun; 12(3):e0136921. PubMed ID: 34154423
[TBL] [Abstract][Full Text] [Related]
15. HIV Vpr Modulates the Host DNA Damage Response at Two Independent Steps to Damage DNA and Repress Double-Strand DNA Break Repair.
Li D; Lopez A; Sandoval C; Nichols Doyle R; Fregoso OI
mBio; 2020 Aug; 11(4):. PubMed ID: 32753492
[TBL] [Abstract][Full Text] [Related]
16. Vpr Targets TET2 for Degradation by CRL4
Lv L; Wang Q; Xu Y; Tsao LC; Nakagawa T; Guo H; Su L; Xiong Y
Mol Cell; 2018 Jun; 70(5):961-970.e5. PubMed ID: 29883611
[TBL] [Abstract][Full Text] [Related]
17. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
Zimmerman ES; Sherman MP; Blackett JL; Neidleman JA; Kreis C; Mundt P; Williams SA; Warmerdam M; Kahn J; Hecht FM; Grant RM; de Noronha CM; Weyrich AS; Greene WC; Planelles V
J Virol; 2006 Nov; 80(21):10407-18. PubMed ID: 16956949
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
[TBL] [Abstract][Full Text] [Related]
20. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
